Literature DB >> 15689383

Mesenchymal progenitor cells localize within hematopoietic sites throughout ontogeny.

Sandra C Mendes1, Catherine Robin, Elaine Dzierzak.   

Abstract

Mesenchymal stem cells (MSCs) have great clinical potential for the replacement and regeneration of diseased or damaged tissue. They are especially important in the production of the hematopoietic microenvironment, which regulates the maintenance and differentiation of hematopoietic stem cells (HSCs). In the adult, MSCs and their differentiating progeny are found predominantly in the bone marrow (BM). However, it is as yet unknown in which embryonic tissues MSCs reside and whether there is a localized association of these cells within hematopoietic sites during development. To investigate the embryonic origins of these cells, we performed anatomical mapping and frequency analysis of mesenchymal progenitors at several stages of mouse ontogeny. We report here the presence of mesenchymal progenitors, with the potential to differentiate into cells of the osteogenic, adipogenic and chondrogenic lineages, in most of the sites harboring hematopoietic cells. They first appear in the aorta-gonad-mesonephros (AGM) region at the time of HSC emergence. However, at this developmental stage, their presence is independent of HSC activity. They increase numerically during development to a plateau level found in adult BM. Additionally, mesenchymal progenitors are found in the embryonic circulation. Taken together, these data show a co-localization of mesenchymal progenitor/stem cells to the major hematopoietic territories, suggesting that, as development proceeds, mesenchymal progenitors expand within these potent hematopoietic sites.

Entities:  

Mesh:

Year:  2005        PMID: 15689383     DOI: 10.1242/dev.01615

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  43 in total

Review 1.  Multipotent mesenchymal stromal cells and the innate immune system.

Authors:  Katarina Le Blanc; Dimitrios Mougiakakos
Journal:  Nat Rev Immunol       Date:  2012-04-25       Impact factor: 53.106

Review 2.  Stem cell interactions in a bone marrow niche.

Authors:  Joan Isern; Simón Méndez-Ferrer
Journal:  Curr Osteoporos Rep       Date:  2011-12       Impact factor: 5.096

Review 3.  Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton.

Authors:  Diptiman Chanda; Sanjay Kumar; Selvarangan Ponnazhagan
Journal:  J Cell Biochem       Date:  2010-10-01       Impact factor: 4.429

4.  Embryonic stromal clones reveal developmental regulators of definitive hematopoietic stem cells.

Authors:  Charles Durand; Catherine Robin; Karine Bollerot; Margaret H Baron; Katrin Ottersbach; Elaine Dzierzak
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-17       Impact factor: 11.205

Review 5.  The regulatory role of stromal microenvironments in fetal hematopoietic ontogeny.

Authors:  Andrea T Badillo; Alan W Flake
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

6.  Phylogenetic fate mapping: theoretical and experimental studies applied to the development of mouse fibroblasts.

Authors:  Stephen J Salipante; James M Thompson; Marshall S Horwitz
Journal:  Genetics       Date:  2008-02-03       Impact factor: 4.562

Review 7.  Mesenchymal progenitor cell research: limitations and recommendations.

Authors:  Ross Summer; Alan Fine
Journal:  Proc Am Thorac Soc       Date:  2008-08-15

Review 8.  Hyaluronan-CD44 interactions as potential targets for cancer therapy.

Authors:  Suniti Misra; Paraskevi Heldin; Vincent C Hascall; Nikos K Karamanos; Spyros S Skandalis; Roger R Markwald; Shibnath Ghatak
Journal:  FEBS J       Date:  2011-03-25       Impact factor: 5.542

Review 9.  Transamniotic Stem Cell Therapy.

Authors:  Stefanie P Lazow; Dario O Fauza
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

10.  Osteoblasts and bone marrow mesenchymal stromal cells control hematopoietic stem cell migration and proliferation in 3D in vitro model.

Authors:  Ana Paula D N de Barros; Christina M Takiya; Luciana R Garzoni; Mona Lisa Leal-Ferreira; Hélio S Dutra; Luciana B Chiarini; Maria Nazareth Meirelles; Radovan Borojevic; Maria Isabel D Rossi
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.